4
Y.-H. Luo et al.
caffeoyl residue. Meanwhile, detailed
NMR analysis showed an additional
hydroxy group in 2. In the 13C NMR
spectrum of 2, C-3 (dC 95.9) was
deshielded by DdC 32.9 as compared to
1, indicating that the hydroxyl group is
located at C-3 in 2. In the HMBC spectrum
of 2, HMBC correlations from Glc-H-100
(dH 4.70) to C-1 (dC 93.1) and H-6 (dH
5.01) to C-90 (dC 168.9) indicated b-D-
glucopyranosyl unit and the caffeoyl ester
group are attached to C-1 and C-6 of
aglycone, respectively. The relative con-
figuration of 2 was established by a
combination of the NOESY experiment
and the biogenetic ground. The small
coupling of H-1 (J ¼ 1.8 Hz) with H-9 (dH
2.62) confirmed the b-orientation of H-9,
since, naturally occurring iridoids display
an a-orientation for H-1 [17–18]. The
large coupling of H-9 (J ¼ 9.6 Hz) with H-
5 (dH 2.09) confirmed the b-orientation of
H-5, demonstrating that the stereochem-
istry of the catalpol ring fusion was cis.
In the NOESY spectrum of 2, the presence
of NOE interactions of H-3/H-5 and H-7/
H-9 indicated that the hydroxy groups at
C-3 and C-7 are in a-positions. Mean-
while, NOE interactions were observed
among H-1, H-6, and H-10, which
indicated the hydroxy groups at C-6 and
C-8 should be b-oriented. Thus, com-
pound 2 was elucidated as 7-O-caffeoyl-3,
6, 8-trihydroxy-8-(hydroxymethyl)cyclo-
penta[c ]pyran-1-O-b-D-glucopyranoside,
named callicoside B.
Table 2. Hepatoprotective effects of com-
pounds 1–2 against D-galactosamine-induced
toxicity in WB-F344 cells.a
Cell survival
rate (% of normal)
Compound
X ^ s
Normal
Control
1.026 ^ 0.037
0.325 ^ 0.076
100
28##
50*
50*
26
Bicyclolb 0.537 ^ 0.049
1
2
0.558 ^ 0.085
0.323 ^ 0.058
a Results are expressed as means ^ SD (n ¼ 3);
##p , 0.001, significantly different from control by
Student’s t-test; *p , 0.05, significantly different
from normal by Student’s t-test.
b Positive control compound.
point apparatus with a microscope and are
uncorrected (Shanghai Eastern Analytical
Instrument Co., Ltd., Shanghai, China).
UV spectra were recorded in MeOH on a
Jasco V650 spectrophotometer (JASCO,
Inc., Easton, MD, USA). The 1H
(600 MHz), 13C (150 MHz), and 2D
NMR spectra were recorded on a Bruker
AVANCE III 600 instrument using TMS
(Tetramethylsilane) as an internal refer-
ence (Bruker Company, Boston, MA,
USA). HRTOFMS data were obtained on
an Agilent 7890-7000A mass spectrometer
(Agilent Technologies, Santa Clara, CA,
USA). Preparative HPLC (high perform-
ance liquid chromatography) was con-
ducted with an Agilent Technologies 1200
series instrument with a MWD (multiple
wavelength detector) using a YMC-pack
ODS (Octadecylsilyl)-A column (5 mm,
250 mm £ 20 mm). Column chromatog-
raphy was performed with silica gel
(200–300 mesh, Qingdao Marine Chemi-
cal Ltd., Qingdao, China), Develosil ODS
(50 mm, Nomura Chemical Co. Ltd.,
Osaka, Japan), Sephadex LH-20 (GE
Healthcare Bio-Sciences AB, Uppsala,
Sweden). TLC (thin layer chromatog-
raphy) was carried out with glass pre-
coated with silica gel GF254. Spots were
visualized under UV light or by spraying
with 10% sulfuric acid in EtOH followed
by heating.
In an in vitro bioassay, compound 1 at
1025 M showed pronounced hepatopro-
tective activities against D-galactosamine-
induced toxicity in WB-F344 rat hepatic
epithelial stem-like cells (Table 2).
3. Experimental
3.1. General experimental procedures
Optical rotations were measured on an
Autopol IV-T/V (Rudolph Research Ana-
lytical, New Jersey, USA). Melting points
were determined on an XT digital melting-